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Immunocontraception of White-Tailed Deer with
GnRH Vaccine
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PROBLEM: Reduction of excess numbers of white-tailed deer (Odocoileus 6irginianus)
is an example of a potential use for immunocontraception as a means of wildlife
population management.
METHOD OF STUDY: A 4 year multifaceted study was conducted to determine the
long term effects of gonadotropin releasing hormone (GnRH) contraceptive vaccine on
the fertility and behavior of female and male white-tailed deer. Deer were monitored
for breeding behavior, hormone levels, pregnancy, fawning and GnRH specific anti-
body levels.
RESULTS: Treatment lead to reduced fawning rates, altered estrus behavior, reduced
concentrations of progesterone, contraception and failure to maintain pregnancy
following conception. GnRH immunized does bred to untreated bucks had an 88%
reduction in fawning caused by either immunocontraception or immunocontragestion.
The vaccine effect is reversible, directly related to the antibody titer. Infertility lasted
up to two years without boosting. GnRH immunized bucks demonstrated no interest
in sexual activity when paired with control females. Depending on the immunization
schedule, antlers either dropped early or remained in velvet.
CONCLUSIONS: The results of this study demonstrate that GnRH vaccine is
effective in inducing a reversible infertility in white-tailed deer, the infertility lasting up
to two years without boosting.
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INTRODUCTION
One of the most successful immunocontraceptive vaccines used for wildlife is
porcine zona pellucida (PZP). Several authors have published on the use of
PZP immunocontraceptive vaccines to immunosterilize white-tailed deer.1–3
This is the first long term study of the use of GnRH contraception of deer.
This GnRH immunocontraceptive study was part of a multi-year White-
Tailed deer infertility study on the deer herd at Pennsylvania State University,
(PSU) University Park, Pennsylvania in cooperation with National Wildlife
Research Center, (NWRC) Fort Collins, CO.
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The effects of immunizing white-tailed deer with
GnRH on reproductive rates, behavior and physiol-
ogy was studied. Since GnRH affects the reproductiv-
ity of both the male and female, one of the effects of
particular interest was the effect of GnRH antibody
on antler development. GnRH controls the level of
testosterone, which in turn controls when bucks rub
off the velvet covering, exposing the hardened antlers
in the fall and separation of the antler from the
pedicel and subsequent shedding of the antlers in the
spring.4–6
Immunization against GnRH prevents circulating
GnRH from binding to pituitary receptors and there-
fore blocks release of the two gonadotropins follicle
stimulating hormone (FSH) and luteinizing hormone
(LH).7 The reduction or absence of serum FSH and
LH leads to atrophy of the gonads and concomitant
infertility in both sexes, effecting a non-surgical cas-
tration in animals.
Immunization with GnRH appears to be highly
specific, and does not appear to affect other hypotha-
lamic releasing hormones. Awoniyi et al.8 demon-
strated that GnRH immunized rats failed to release
FSH and LH, but that other pituitary hormones and
their vital non-sexual functions were not impaired.
GnRH contraceptive vaccines have been evaluated
as immunocastration agents in pets,9 cattle,10,11
horses,12 sheep,13 and swine.14 Recently, in studies
with Norway rats,15 we found that both males and
females immunized with a GnRH vaccine were 100%
infertile. Given these impressive results and the highly
specific target of the GnRH vaccine, it was decided to
evaluate the efficacy of a GnRH contraceptive vaccine
in white-tailed deer. The objectives of this study were
to administer the GnRH vaccine to male and female
deer to determine its effectiveness in reducing fertility
and evaluate its general impact on the physiology of
reproduction in order to better understand the vac-
cine’s mechanism of action.
MATERIALS AND METHODS
GnRH Antigen Preparation
The 10 amino acid GnRH, which is conserved among
all mammals, was made immunogenic by coupling
to the carrier keyhole limpet hemocyanin (KLH).
The GnRH used in this study was synthesized
at Macromolecular Resources, Colorado State
University (Ft. Collins, CO) with the structure
[pEHWSYGLRPGGC-SH]. A glycine was added at
the C terminus as a spacer and a cysteine was added
to provide a coupling agent to maleimide on KLH.
This design also insured that coupling only occurred
at the C terminus end of GnRH. The underlined
amino acids represent the native GnRH molecule.16–19
This GnRH analogue, called GnRH-glycys17 appar-
ently has a similar conformation to native GnRH.20
Maleimide-activated KLH was purchased from Pierce
Chemical Co. (Rockford, IL), and the C-terminal
Cys-GnRH was coupled to the activated KLH using
the method described by the manufacturer. Briefly,
both KLH-maleimide and the peptide were
lyophilized. For coupling both of the reagents were
rehydrated and immediately mixed together in a 1:1
w:w ratio. The reaction was allowed to proceed for 2
hr at room temperature. Free peptides were separated
from the preparation using a G-25 sephadex column.
The void volumn off the column, containing KLH-
GnRH, was use for the vaccine.
Animals Used and Immunization Schedule
The animals in the study were in a 17 acre fenced
facility containing several paddocks for separation of
study groups. The facility has holding pens and shoots
which allow the deer to be accessed for injection and
blood draws.
In this 4 year study on the effectiveness of KLH-
GnRH vaccine to immunocontracept deer, eight fer-
tile does and four fertile bucks were injected
subcutaneously with one primary immunization fol-
lowed later by booster doses all containing 1 mL of
vaccine distributed among several sites at the center of
the back between the scapulae. All deer received a
prime dose containing 500 mg of KLH-GnRH in
saline mixed 1:1 with complete Freund’s adjuvant
(CFA) and approximently 1 month later were given a
boost containing 300 mg of KLH-GnRH mixed 1:1
with incomplete Freund’s adjuvant (IFA). Additional
boost injections were given on a yearly basis depend-
ing on the current antibody titer. Fawning results of
the GnRH-treated does were compared to the fawning
rates of sham (saline mixed with Freund’s adjuvant)
treated does and fawning of the does from the herd
not involved in the study.
Measurements of Vaccine Effecti6eness
The biological effects of the GnRH vaccine were
measured by: (1) The immune response to the vaccine
by measuring the specific antibody to GnRH, (2)
Determining the blocking effect of the GnRH anti-
body by measuring the reduction in serum proges-
terone concentrations in the does and testosterone
concentrations in the bucks, (3) Use of ultrasound in
February, and palpation in April as a measure of
pregnancy and maintaince of pregnancy, (4) Behav-
ioral responses during the rut period to insure that
any change in behavior in not detrimental to the deer.
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(5) Natality responses, as it is the ultimate result of
the contraceptive treatment.
Blood samples were taken immediately before the
prime injection, immediately before each boost, and
several times throughout the fall and winter. Blood
serum samples were analyzed for immune response by
ELISA and tested for progesterone or testosterone by
RIA.
Normally, the does from this herd become pregnant
in November or December; therefore, to differentiate
between failure to conceive and failure of fetal mainte-
nance, trans-rectal ultrasound was performed in late
January or early February to detect placental cotyle-
dons (plascentomes) or fetuses.21 Because it is known
that progesterone is needed for maintenance of preg-
nancy,22–25 blood was drawn the same day of the
ultrasound and tested for serum progesterone concen-
tration levels. Fetal development was monitored in the
does by palpating the abdomen externally between
late April and mid May. The results of these early
detection techniques were compared with fawning to
determine if evidence existed for the death and resorp-
tion of the fetus during gestation.26
In the ELISA test used to assess the immune re-
sponse to the GnRH vaccine, a 96-well plate was
prepared by adding 100 ng of BSA-GnRH antigen to
each well and blocking with PBS-2% powdered milk.
Since KLH-GnRH was used in the vaccine, we used
BSA-GnRH on the plate, thus detecting only anti-
body to GnRH.
Plasma testosterone in the males and plasma
progesterone in the females were assayed by the coat-
a-tube RIA method (Diagnostic Products, Los Ange-
les, CA). Fifty micro liters of serum were used for
each assay.
The estrus activity of rutting behavior of the
GnRH-treated deer was compared to control deer in
the open pen natural setting. Observations were con-
ducted for 2 hr each time, three times daily from
November 7 through February 12, and two times
daily until February 28. Estrus activity was considered
as any of the following behavior of males towards
females: vaginal sniffing, pursuit, aggressive guarding,
and mounting and copulation.
RESULTS
Fawning Data
There was no apparent change in the outward appear-
ance of the treated or control females as the breeding
season approached. Behaviorally, the first estrous cy-
cle brought an increased interest in the does by the
bucks. The control deer in the study were generally
bred the first time they came into estrus. As deter-
mined by the fawning dates, breeding was essentially
complete during the month of November.
Of the original four does that were immunized with
GnRH vaccine and followed for 4 years, two of the
four deer remained infertile throughout the study
(Fig. 1a, b). Deer number 428 remained infertile with-
out boosting the 3rd and 4th years. The antibody titer
on deer number 578 began to drop and the deer was
boosted. The titer increased after the boost and the
deer remained infertile. The antibody titer in deer
number 471 was low in the third year, but the deer
was not boosted and conceived in the fourth year
(Fig. 2a). Deer number 517 died of a treatment unre-
lated cause in the 2nd year; however, autopsy indi-
cated that she was not pregnant (Fig. 2b). Three
fawns were born to these four does during the 4 years,
or three fawns:14 doe years (doe years the number
of does times the number years tested), compared to
25 fawns:14 doe years in the control deer during this
same period of time.
Of the four additional does given GnRH treatment
in the third year, one fawn was born during the first
year. With the additional group of does added there
were five fawns:24 doe years (0.21 fawns:doe:year) as
compared with 35 fawns:19 doe years (1.8 fawns:doe:
year) in the sham-treated group. This represents an
88% reduction (PB0.01) in fawning in the GnRH
group compared with the sham controls. The average
of 1.7 fawns:doe:year is representative of the average
reproduction in normal breeding herd at PSU for
these 4 years (Table I). Fawns born to the GnRH-
treated deer appeared healthy and normal.
Beha6ioral Obser6ations
Estrus in the GnRH-treated does as compared to the
control does was determined by the sexual interest of
the buck in the doe. The most common sexual activity
observed was confined to bucks sniffing the does and
short pursuits of bucks chasing does. GnRH-treated
does were observed having zero to two estrus events
with a mean of 0.6590.16 (SE) estrus events for a
period of 30 days during the rutting season as com-
pared to the controls which were observed in estrus
0–2 times with a mean of 0.9590.14 (SE) (P\0.05)
estrus event for a period of 44 days during the rutting
season.
Antibody Titers
In the four does treated the first two years, peak
antibody titers ranged from 64,000 to 128,000. These
deer demonstrated reduced estrous activity and re-
duced fertility. The deer with these high titers had
negative ultrasound evaluation for pregnancy in late
January. (Fig. 1a, b)
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The deer that did not conceive had low serum
progesterone concentrations at the time of ultrasound.
During the third year, with no boosting, anti-GnRH
antibody titers in the three remaining does dropped to
16,000–32,000 in October and November. Even
though all deer had a positive ultrasound indicating
the presence of fetuses on February 4, none of the
deer fawned. At this time, serum progesterone concen-
trations were almost non-detectable which is inconsis-
tent with successful pregnancies. Accordingly,
palpation for viable fetuses was negative for all three
deer in April of this year. (Figs. 1 and 2, year 1996–
1997)
Progesterone Concentrations
Studies on the control deer suggest serum proges-
terone in late January to early February is predictive
of success or failure of pregnancy. The data suggest
that non-pregnant deer have serum progesterone con-
centration of less than 1.0 ng:mL and serum proges-
terone concentrations of 4 ng:mL or greater correlates
with fawning success in the control deer. The treated
deer followed the same pattern. During the 4 year
study consisting of 22 GnRH doe years, 15 of the
February progesterone levels were 1.0 ng:mL or less
and these does failed to fawn. Four had levels greater
than 4.0 ng:mL and produced fawns. The other three
Fig. 1. Correlation between anti-
GnRH titers, progesterone levels, ul-
trasound measurements, palpations
and fawning. (a) Shows a deer with no
fawns for 4 years and not vaccinated
the last 2 years. (b) Shows a deer with
no fawns for 4 years, however the titer
began to drop after the third year and
the deer was boosted on the fourth
year.
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Fig. 2. Correlation between anti-
GnRH titers, progesterone levels, ul-
trasound measurements, palpations
and fawning. (a) Shows a deer with
no fawns for 3 years; however, in
year 3, the titer dropped and the
ultrasound became positive indicat-
ing conception. In this situation,
GnRH acted as a contragestive
agent. In the 4th year the deer recov-
ered from the infertility and had two
fawns. (b) This GnRH-treated deer
was not contracepted the first year,
the palpation was questionable be-
cause of only one fawn. With a boost
the second year, the deer became in-
fertile.
had progesterone levels of 2.2, 2.7 and 3.8 ng:mL and
had positive or questionable ultrasounds but failed to
produce a fawn (Figs. 1 and 2).
During the GnRH study, blood was drawn monthly
from September or October through the end of Janu-
ary or the beginning of February. In September, be-
fore the start of the first estrous cycle of the breeding
season, the serum progesterone ranged from B0.1 to
1.8 ng:mL. After the beginning of the first cycle, the
measured levels of 3.7–11.8 ng:mL indicate that the
deer were in the postovulatory luteal phase of the
estrous cycle or that they were pregnant.
Ultrasound and Palpation
Ultrasound has been shown to be an excellent predic-
tor of early pregnancy.24 In control animals, a positive
ultrasound observation in late January or early Febru-
ary and a positive palpation in April or May is
predictive of fawning. The only exceptions we have
noted were when does conceived late in the season;
consequently, the ultrasounds and palpations may
have been performed too early to detect pregnancy.
Compared to control does, the ultrasound and palpa-
tion were less accurate at predicting pregnancy in the
GnRH-treated does. In the 1996–1997 breeding sea-
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son, 6 of 8 does had a positive ultrasound. However,
in both April and May these fawns could not be
palpated and none of the 6 does fawned that spring.
The 7th doe had a positive ultrasound palpations were
positive, and she gave birth to one fawn in June.
Male Deer
Control bucks in our study had non-breeding season
serum testosterone concentrations of less than 100
ng:l00 mL, and developed normal breeding levels of
testosterone (350 to \400 ng:100 mL) in October and
peak breeding activity occurred in November when
bucks were introduced to does. Antlers grew slowly
early in the summer but rapid growth ensued in
August and September. The antlers remained in velvet
until September at which time the velvet was rubbed
off on nearby trees. The antlers dropped off in March
of the following year (Fig. 3a).
The bucks in the GnRH group were treated the first
year with a prime dose in September and boosts in
October. They lost their already hardened antlers 2
weeks after the second boost (between October 20–
28). The testes were less then one half the size of
normal bucks. They did not develop the prominent
neck musculature normally observed in the fall on
mature bucks and therefore looked very much like a
doe throughout the breeding season. Treated bucks
were penned with untreated cycling does, but demon-
strated little sexual interest in the does. Serum testos-
terone levels for the GnRH-treated bucks ranged from
Fig. 3. Relationship between testosterone levels, antler velvet rub-
off, shedding of antlers and GnRH antibody titers in the GnRH-
treated male deer. (a) Antler velvet rub-off and shedding of antlers
correlates with testosterone levels. (b) The rise in anti-GnRH titers
suppressed testosterone levels resulting in early shedding of antlers.
(c) In the second year, the antlers of the GnRH-treated males
remain in velvet because of the low testosterone. These antlers
broke off in January.
TABLE I. Summary of Fawns Born in the GnRH
Treated Group as Compared to the Sham-Treated
Group (P\0.01). Sham Treated Group Demonstrated
no Effect as Compared to the Fawning Rate of the
Deer Herd not on Study (P\0.05).
TreatmentYear Fawns:Does
Primed &94–95 1:4
boosted
0:495–96 Primed &
boosted
1:8Boosted96–97
3:897–98 No boost
156:90Breeding herd
(x¯1.7)
35:19Sham controls
(x¯1.8)
GnRH-treated 5:24
88% reduction in (x¯0.21)
fawns in GnRH group
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11–74 ng:100 mL throughout the breeding season,
which are in the range of non-breeding testosterone
concentrations. Antibody titers to GnRH ranged from
12,000 to 128,000 during the fall period (Fig. 3b).
In the second year, three of the bucks were boosted
with the KLH-GnRH vaccine in July and August.
The fourth buck died before the start of the second
year of research. The anti-GnRH titers peaked in
September. The testosterone of these bucks remained
less than 30 ng:100 mL throughout the breeding sea-
son. In contrast to the first year, the antlers remained
in velvet throughout the fall. The antlers never cleaved
normally at the base of the pedicel, but instead broke
off one to four inches above the pedicel between
January 10 and February 13 (Fig. 3c). This breakage
was likely a result of freezing temperatures which
killed the unhardened antler, thereby resulting in re-
duced antler strength.
In the third year, the three bucks were not boosted
in order to observe the long term effects of the GnRH
vaccine. One of the three bucks died in early January,
1997. Histology indicated that testicular regression
had occurred in this buck when compared with those
of a wild buck killed in late December, 1996. The
diameter of the seminiferous tubules of the treated
buck were less than 50% that of the control tissue. In
addition, the germinal epithelium of the treated buck
only contained spermatogonia in contrast to the con-
trol tissue which contained a full complement of cell
types including mature spermatids. The treated buck
did not appear to be capable of reproduction at the
time of death. One of the two remaining bucks did not
develop any sexual activity. Serum testosterone was
less than 10 ng:100 mL, his testicles remained small in
size, and the antlers remained in velvet until breaking
off 1 inch above the pedicle as in the second year.
However, the third buck developed normal sexual
activity, including testosterone levels of 300 ng:100
mL, normal testicle size, and normal hardening of the
antlers.
The sexual responses of the bucks were directly
related to the anti-GnRH titers throughout the 3
years. The bucks that remained sterile had GnRH
titers of 4000–16,000 as compared to a 1000–2000
titer in the fertile buck. When the GnRH-treated
fertile buck was put in with control females he demon-
strated sexual interest in the does in estrous.
DISCUSSION
Female Deer
The results of our study indicate the GnRH vaccine is
effective in reducing fertility in the doe by either
contraception or contragestion. Although all deer re-
sponded to the vaccine, variation in antibody titer
among deer was noted. Variations in immune re-
sponse, and resultant differences in reproductive phys-
iology is consistant with past observations in
immunocontraception, and is thought to be due to
genetic differences among individual animals.
There were less estrus events observed in the
GnRH-treated deer as compared to the control deer,
both groups were observed to have a mean of less
than one estrus event per season. It is obvious that
some estrus events were missed since all control deer
became pregnant. The PZP contracepted deer in a
former study2 were observed to have a mean of 3.6
estrus events over a period of 98 days. With the
normal rutting period of 44 days at the facility, it was
important to note that the GnRH immunocontracep-
tive treatment did not increase the length of rut. This
is an important consideration since it is believed that
increased deer:car collisions are associated with the
rutting season.
Infertility was directly related to anti-GnRH titers
above 64,000 with infertility lasting up to 2 years
without boosting. As the antibody titer dropped the
deer became fertile again, usually having one fawn the
first year.
Numerous studies indicate GnRH immunocontra-
ception results in immunocastration of both sexes,
that is, the drop in biologically active GnRH reduces
LH and FSH release, and consequently reduces go-
nadal steroid production. The deer remains infertile as
long as the antibody neutralizes the endogenous
GnRH. Norway rat15 studies demonstrated this im-
munocontraceptive effect in both sexes, which lasted
for the life expectancy of the rat in the field (approxi-
mately 1 year). In the present 4 year study, we found
that the contraceptive effect may last up to 2 years
without boosting.
Interestingly, if the antibody titer is sufficiently
high, the doe does not appear to ovulate or produce a
functioning corpus luteum as evidenced by the low
progesterone level during the period when ovulation
should be occurring. This study also demonstrates
that some does with low antibody titers apparently
release enough LH to ovulate and conceive, but the
progesterone produced by the corpus luteum is not
enough to maintain the pregnancy.
Although the placenta serves as a source of proges-
terone, the placental contribution of progesterone in
early pregnancy is not sufficient to maintain preg-
nancy without the progesterone from the corpus lu-
teum.26 In studies by Plotka et al.25, ovariectomy of
deer at 100 or 156 days of gestation reduced proges-
terone levels and resulted in termination of pregnancy.
These experiments demonstrate that the ovaries are
the principal source of progesterone through the first
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156 days of the normal 200 day gestation in the
white-tailed deer, and that ovarian progesterone is
essential for maintenance of pregnancy. It appears,
therefore, that antibody neutralization of endogenous
GnRH affects the production of ovarian progesterone
by the corpus luteum needed for maintenance of
pregnancy. Russell 27 found that the serum proges-
terone concentration was an excellent indicator of
early pregnancy. He used the drop in progesterone as
evidence of embryonic mortality in lactating caribou
that were in poor condition.
Male Deer
The GnRH-treated bucks in our study demonstrated
characteristics similar to those of a castrated male
with a resultant testicular regression. This same testic-
ular regression was observed by Oonk et al.16 in
GnRH-treated male pigs, and in our GnRH-treated
male Norway rats.15 Treated bucks shared feeders
with control females that were in estrus, but had little
interest in sexual activity. They were not considered a
competitive threat to the dominant buck and were
ignored by it. In the normal buck, the rise in FSH and
LH in the fall governs testicular sperm production
and testosterone secretion, which in turn modulates
muscle and antler development. The slow growth of
the velvet antler in spring is consistent with the low
level of testosterone present throughout the spring
and summer. The rapid antler growth in the latter half
of summer and shedding of velvet in September is
consistent with a rapid rise in testosterone in the same
time period in response to the shortened day length.
The shedding of the antlers in February or March
corresponds to a drop in testosterone in response to
the increasing day length. Sperm production begins in
mid-August and extends through March, with peak
sperm production in mid-November and dropping in
half by mid-December.5
If a buck is castrated while its antlers are in velvet,
they are retained, and do not harden or lose their
velvet. An animal castrated after the velvet is shed
loses its antlers within a week and the antlers regrow
the next year. However, the antlers will remain in
velvet the second year and will not have the normal
spring drop.5 The response of the bucks in this study
to the GnRH vaccine mimics that of physical castra-
tion, and therefore is appropriately called immunocas-
tration.
Conclusion
In this study, we have shown that KLH-GnRH vac-
cine is an effective immunocontraceptive or an im-
munocontragestive vaccine in the white-tailed deer.
Fawning rates were reduced by 88% when GnRH-
treated does were paired with fertile bucks. The
GnRH conjugate produced high antibody titers result-
ing in infertility for up to 2 years without boosting. It
appears that this vaccine is reversible; that is, when
the antibody titer drops, fertility is restored. Further-
more, the deer could be boosted again, causing the
deer to again become infertile. There was little differ-
ence in the observed behavioral effects between the
GnRH-treated does and the control does. GnRH-
treated bucks, on the other hand, lost most sexual
interest in the does coming into estrus. Early antler
loss and the absence of antler hardening may be
considered negative side effects of treating bucks. The
study also shows that the GnRH vaccine reduces the
reproductive behavior associated with the rutting sea-
son. Given these characteristics, a GnRH vaccine may
be acceptable to address the increasing problem of
deer:car accidents which appear to increase with in-
creased deer movements associated with the breeding
season.
GnRH vaccination may have limited application for
immunosterilizing bucks in field situations because of
its effect on antler growth; however, it may be useful
in parks or non-huntable populations where the ag-
gressive behavior of the buck in the fall is an undesir-
able safety concern. Assuming an oral GnRH vaccine
can be developed,28 it would also be necessary to
consider species specificity in the delivery of the bait,
since GnRH is not species specific. Additionally, if the
effects on antler growth were a concern, a feeder that
prevented antlered bucks from getting into the bait
could be used to selectively contracept does in the
field.
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